rs3796123

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_212482.4(FN1):​c.1819+7A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.264 in 1,612,308 control chromosomes in the GnomAD database, including 70,263 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 7473 hom., cov: 32)
Exomes 𝑓: 0.26 ( 62790 hom. )

Consequence

FN1
NM_212482.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0005096
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.99

Publications

15 publications found
Variant links:
Genes affected
FN1 (HGNC:3778): (fibronectin 1) This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. The encoded preproprotein is proteolytically processed to generate the mature protein. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. The full-length nature of some variants has not been determined. [provided by RefSeq, Jan 2016]
FN1 Gene-Disease associations (from GenCC):
  • spondylometaphyseal dysplasia, 'corner fracture' type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics, ClinGen
  • glomerulopathy with fibronectin deposits 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • fibronectin glomerulopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 2-215419235-T-A is Benign according to our data. Variant chr2-215419235-T-A is described in ClinVar as [Benign]. Clinvar id is 1165946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FN1NM_212482.4 linkc.1819+7A>T splice_region_variant, intron_variant Intron 12 of 45 ENST00000354785.11 NP_997647.2 P02751-15Q6MZM7Q9UQS6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FN1ENST00000354785.11 linkc.1819+7A>T splice_region_variant, intron_variant Intron 12 of 45 1 NM_212482.4 ENSP00000346839.4 P02751-15

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
42694
AN:
151986
Hom.:
7476
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.226
Gnomad AMI
AF:
0.158
Gnomad AMR
AF:
0.420
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.924
Gnomad SAS
AF:
0.268
Gnomad FIN
AF:
0.291
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.230
Gnomad OTH
AF:
0.295
GnomAD2 exomes
AF:
0.336
AC:
84332
AN:
251100
AF XY:
0.323
show subpopulations
Gnomad AFR exome
AF:
0.225
Gnomad AMR exome
AF:
0.521
Gnomad ASJ exome
AF:
0.359
Gnomad EAS exome
AF:
0.924
Gnomad FIN exome
AF:
0.279
Gnomad NFE exome
AF:
0.234
Gnomad OTH exome
AF:
0.310
GnomAD4 exome
AF:
0.263
AC:
383513
AN:
1460204
Hom.:
62790
Cov.:
32
AF XY:
0.262
AC XY:
190272
AN XY:
726526
show subpopulations
African (AFR)
AF:
0.223
AC:
7470
AN:
33444
American (AMR)
AF:
0.511
AC:
22829
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
9283
AN:
26114
East Asian (EAS)
AF:
0.936
AC:
37141
AN:
39688
South Asian (SAS)
AF:
0.253
AC:
21817
AN:
86214
European-Finnish (FIN)
AF:
0.275
AC:
14688
AN:
53404
Middle Eastern (MID)
AF:
0.322
AC:
1854
AN:
5766
European-Non Finnish (NFE)
AF:
0.226
AC:
250762
AN:
1110544
Other (OTH)
AF:
0.293
AC:
17669
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
12112
24223
36335
48446
60558
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8930
17860
26790
35720
44650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.281
AC:
42709
AN:
152104
Hom.:
7473
Cov.:
32
AF XY:
0.290
AC XY:
21587
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.226
AC:
9361
AN:
41472
American (AMR)
AF:
0.420
AC:
6413
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1252
AN:
3470
East Asian (EAS)
AF:
0.923
AC:
4768
AN:
5166
South Asian (SAS)
AF:
0.268
AC:
1289
AN:
4818
European-Finnish (FIN)
AF:
0.291
AC:
3073
AN:
10578
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.230
AC:
15671
AN:
68004
Other (OTH)
AF:
0.303
AC:
639
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1425
2851
4276
5702
7127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.256
Hom.:
1796
Bravo
AF:
0.296
Asia WGS
AF:
0.552
AC:
1919
AN:
3478
EpiCase
AF:
0.248
EpiControl
AF:
0.248

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Glomerulopathy with fibronectin deposits 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spondylometaphyseal dysplasia - Sutcliffe type Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
9.5
DANN
Benign
0.62
PhyloP100
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00051
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3796123; hg19: chr2-216283958; COSMIC: COSV60546882; COSMIC: COSV60546882; API